Science & Research
Alpha Cognition to Present at Spartan Capital Investor Conference, Highlighting Neurodegenerative Disease Treatments
Alpha Cognition's participation in the Spartan Capital Securities investor conference provides a platform to showcase its innovative treatments for Alzheimer's and cognitive impairment from traumatic brain injury, potentially attracting crucial investment for addressing unmet medical needs.
University of Utah Enzyme Discovery Enables Programmable Peptide Modifications for Next-Generation Diabetes and Obesity Treatments
University of Utah researchers have developed an enzyme technology that can stabilize and enhance therapeutic peptides for diabetes and obesity treatments, with the innovation now advancing toward clinical development through spinout company Sethera Therapeutics.
FDA Approves One-Minute HIV Self-Test in Major Public Health Advancement
The FDA's approval of bioLytical's INSTI® HIV Self Test, which provides results in 60 seconds, represents a significant step toward reducing undiagnosed HIV cases and supporting national goals to end the HIV epidemic by making testing more accessible and private.
TransCode Therapeutics Advances Cancer Treatment with Successful Phase 1a Trial of TTX-MC138
TransCode Therapeutics has successfully completed Phase 1a clinical trials for TTX-MC138, an RNA-based cancer treatment targeting metastatic disease, showing promising safety results and disease stabilization in nearly half of patients, advancing to Phase 2 evaluation.
Soligenix Strengthens Medical Advisory Board to Advance HyBryte CTCL Treatment Through Phase 3 Development
Soligenix has updated its U.S. Medical Advisory Board with leading dermatologic and oncologic experts to guide the Phase 3 development and potential commercialization of HyBryte, a novel photodynamic therapy for cutaneous T-cell lymphoma that addresses significant unmet medical needs.
ESGold Corp. Reports Promising Metallurgical Results from Colombian Gold Recovery Project
ESGold Corp. announced positive initial metallurgical test results from its Colombian tailings project, demonstrating significant gold recovery potential using environmentally friendly gravity separation methods without chemical reagents.
Eldridge Engineers Combat Cold Storage Hazards Through Psychrometric Analysis
Eldridge engineers are using psychrometric charts to address humidity-related safety and efficiency challenges in cold storage facilities, shifting from reactive problem-solving to proactive prevention.
Women Face Significant Barriers in Cardiac Rehabilitation Access Despite Proven Health Benefits
A new scientific statement reveals women face substantial obstacles in accessing cardiac rehabilitation programs despite experiencing greater mortality reductions than men, highlighting urgent need for systemic changes to improve cardiovascular outcomes for female patients.
BeSang Announces Breakthrough TRUE 4F2 DRAM Technology Overcoming Industry Scaling Limits
BeSang's development of TRUE 4F2 DRAM technology represents a significant advancement in semiconductor memory, potentially transforming AI computing and high-performance applications by overcoming long-standing density and cost barriers.
BioMed X Launches Women's Health R&D Accelerator with Gates Foundation Support
BioMed X has launched XFem Labs, a women's health research accelerator in Heidelberg focused on developing non-hormonal contraceptive solutions to address global access barriers and high discontinuation rates of current methods.
Harvard AI System Revolutionizes Brain Tumor Diagnosis During Surgery
Harvard Medical School researchers have developed an AI tool called PICTURE that achieves 99.8% accuracy in distinguishing between glioblastoma and primary central nervous system lymphoma during surgery, potentially transforming treatment outcomes for brain cancer patients.
GeoVax Executives Pursue European Partnerships to Advance Vaccine and Cancer Therapy Development
GeoVax Labs is intensifying European partnership efforts to accelerate development of vaccines for mpox, COVID-19, and cancer therapies, addressing critical global health needs.
Cancer Treatment Support Needs Drive Biotech Innovation
The emotional and physical challenges faced by cancer patients during treatment are motivating biotech companies like Soligenix to develop new therapeutic approaches while highlighting the importance of patient-focused support strategies.
Lifordi Immunotherapeutics Reports Promising Preclinical Data for Autoimmune Treatment LFD-200
Lifordi Immunotherapeutics will present new preclinical data showing its antibody drug conjugate LFD-200 delivers glucocorticoids directly to immune cells with sustained anti-inflammatory effects and no systemic toxicity, potentially offering a safer treatment option for autoimmune diseases.
Andrew Hillman Grant Launches to Support Next Generation of Biotech Innovators
The Andrew Hillman Grant for Biotech offers $1,000 to undergraduate students pursuing biotechnology careers, representing a strategic investment in future healthcare and technology leaders.
Palm Beach Symphony to Host Panel on Arts' Impact on Physical and Mental Wellness
The annual Music, Maestros & Masters event brings together experts from music, science, health and athletics to explore how arts engagement fuels cognitive vitality, physical performance and emotional wellness.
Glioblastoma Found to Erode Skull Tissue, Challenging Long-Held Treatment Assumptions
A recent study reveals that glioblastoma, the deadliest form of brain cancer, erodes patients' skulls, challenging the long-held assumption that the disease is localized and potentially explaining why current therapies have shown dismal success rates.
Soligenix Expands European Medical Advisory Board to Advance CTCL Treatment Development
Soligenix is strengthening its European medical advisory board and advancing Phase 3 clinical trials for HyBryte, a potential new treatment for cutaneous T-cell lymphoma that addresses significant unmet medical needs in European patients.
American Heart Association Launches Data Challenge to Transform Food and Nutrition Information
The American Heart Association's Periodic Table of Food Initiative data challenge aims to translate complex molecular food data into accessible visualizations that could revolutionize how consumers, policymakers and industry leaders understand nutrition and sustainability.
Annovis Bio Reports Buntanetap Shows Promising Biomarker Improvements in Alzheimer's Patients
Annovis Bio's buntanetap demonstrated significant reductions in inflammatory biomarkers and improved neuronal health markers in Alzheimer's patients, suggesting potential disease-modifying effects for neurodegenerative conditions.
GeoVax to Present COVID-19 Vaccine Data for Immunocompromised Patients at European Vaccine Congress
GeoVax Labs will present interim safety data and special-population insights for its GEO-CM04S1 COVID-19 vaccine at the World Vaccine Congress Europe 2025, highlighting progress in addressing vaccine needs for immunocompromised patients where current options remain insufficient.
Oncotelic's Injectable Everolimus Shows Promise for Dramatically Improved Breast Cancer Treatment
Oncotelic Therapeutics has received clearance to begin Phase 1 clinical trials for Sapu003, an injectable form of Everolimus that could increase drug bioavailability from 10% to up to 100%, potentially transforming breast cancer treatment efficacy.
TransCode Therapeutics Acquires Polynoma, Secures $25 Million Investment to Advance Oncology Pipeline
TransCode Therapeutics has acquired Polynoma and secured $25 million from CK Life Sciences to advance its Phase 2 trial of TTX-MC138 and Phase 3-ready melanoma vaccine seviprotimut-L, positioning the company to deliver meaningful therapeutic advances for patients battling melanoma and metastatic disease.
New Research Identifies Key Mechanism Behind Cancer Immunotherapy Failures
Ohio State University researchers have discovered a previously unknown stress pathway that explains why immunotherapy fails in most cancer patients, potentially paving the way for more effective treatments.
Oncotelic Therapeutics Announces Phase 1 Trial Enrollment for Novel Intravenous Everolimus Formulation in Australia
Oncotelic Therapeutics has opened enrollment for the first clinical trial of Sapu-003, an intravenous Deciparticle formulation of everolimus that represents a significant advancement in mTOR-targeted cancer therapy delivery for patients with advanced breast cancer and other malignancies.
UT Southwestern Cardiologist Amit Khera Receives Prestigious 2025 Chairman's Award from American Heart Association
Dr. Amit Khera's recognition highlights his transformative contributions to preventive cardiology, including developing NASA's astronaut heart risk calculator and advancing cardiovascular disease prevention through innovative research and leadership.
Soligenix's HyBryte Therapy Shows Positive Safety Profile in Phase 3 CTCL Trial
Soligenix's HyBryte therapy demonstrated a positive safety profile in its ongoing Phase 3 FLASH2 study for cutaneous T-cell lymphoma, maintaining progress toward potential regulatory approval and commercialization as a first-line treatment option.
Lund University Researchers Identify Mechanism Allowing Leukemia Cells to Evade Immune System
Researchers at Lund University have discovered why acute myeloid leukemia cells resist immunotherapy, potentially paving the way for more effective treatments for this aggressive blood cancer.
GeoVax CEO to Present at ROTH Healthcare Conference, Highlighting Vaccine and Cancer Therapy Pipeline
GeoVax Labs' participation in the ROTH Healthcare Opportunities Conference provides investors with insights into the company's advancing vaccine and cancer therapy pipeline, including progress on Mpox, COVID-19 vaccines, and oncology treatments.
Stanford Study Shows Pulsed Shortwave Therapy Provides Sustained Pain Relief for Thumb Arthritis
A Stanford University clinical trial demonstrates that pulsed shortwave therapy offers lasting pain relief for thumb arthritis, potentially providing a safe, drug-free alternative to current limited treatment options for millions of affected adults.